drugset / Trial / NCT02356107
5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females
NaSingle-groupOpen-labelTreatment
Summary
The investigators hypothesize that the administration of two widely available, naturally occurring dietary supplements, 5 hydroxytryptophan and creatine monohydrate, will reduce the severity of depression in individuals exposed to chronic hypoxia by living at altitude. The purpose of this study is to determine if 8 weeks of dietary augmentation with oral 5 g creatine daily and 100 mg 5-HTP twice daily reduces hypoxia-related depressive symptoms measured by the 17-item Hamilton Depression Rating Scale (HAM-D) in women with SSRI or SNRI-resistant depression.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 5-Hydroxytryptophan | Other / unclassified | 100 mg | Oral |
| Subject | Creatine | Other / unclassified | 5 g | Oral |